These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
604 related articles for article (PubMed ID: 31115798)
1. S1PR1 as a Novel Promising Therapeutic Target in Cancer Therapy. Rostami N; Nikkhoo A; Ajjoolabady A; Azizi G; Hojjat-Farsangi M; Ghalamfarsa G; Yousefi B; Yousefi M; Jadidi-Niaragh F Mol Diagn Ther; 2019 Aug; 23(4):467-487. PubMed ID: 31115798 [TBL] [Abstract][Full Text] [Related]
2. Interleukin-22 Mediates the Chemotactic Migration of Breast Cancer Cells and Macrophage Infiltration of the Bone Microenvironment by Potentiating S1P/SIPR Signaling. Kim EY; Choi B; Kim JE; Park SO; Kim SM; Chang EJ Cells; 2020 Jan; 9(1):. PubMed ID: 31935914 [TBL] [Abstract][Full Text] [Related]
3. Coinhibition of S1PR1 and GP130 by siRNA-loaded alginate-conjugated trimethyl chitosan nanoparticles robustly blocks development of cancer cells. Rostami N; Nikkhoo A; Khazaei-Poul Y; Farhadi S; Sadat Haeri M; Moghadaszadeh Ardebili S; Aghaei Vanda N; Atyabi F; Namdar A; Baghaei M; Haghnavaz N; Kazemi T; Yousefi M; Ghalamfarsa G; Sabz G; Jadidi-Niaragh F J Cell Physiol; 2020 Dec; 235(12):9702-9717. PubMed ID: 32424937 [TBL] [Abstract][Full Text] [Related]
4. S1PR1 promotes proliferation and inhibits apoptosis of esophageal squamous cell carcinoma through activating STAT3 pathway. Liu Y; Zhi Y; Song H; Zong M; Yi J; Mao G; Chen L; Huang G J Exp Clin Cancer Res; 2019 Aug; 38(1):369. PubMed ID: 31438989 [TBL] [Abstract][Full Text] [Related]
5. Endothelial sphingosine 1-phosphate receptors promote vascular normalization and antitumor therapy. Cartier A; Leigh T; Liu CH; Hla T Proc Natl Acad Sci U S A; 2020 Feb; 117(6):3157-3166. PubMed ID: 31988136 [TBL] [Abstract][Full Text] [Related]
6. Preclinical study of the antitumor effect of sphingosine-1-phosphate receptor 1 antibody (S1PR Xiao S; Yang J Invest New Drugs; 2019 Feb; 37(1):57-64. PubMed ID: 29860604 [TBL] [Abstract][Full Text] [Related]
7. Endoplasmic reticulum resident oxidase ERO1-Lalpha promotes hepatocellular carcinoma metastasis and angiogenesis through the S1PR1/STAT3/VEGF-A pathway. Yang S; Yang C; Yu F; Ding W; Hu Y; Cheng F; Zhang F; Guan B; Wang X; Lu L; Rao J Cell Death Dis; 2018 Oct; 9(11):1105. PubMed ID: 30377291 [TBL] [Abstract][Full Text] [Related]
8. Macrophage S1PR1 Signaling Alters Angiogenesis and Lymphangiogenesis During Skin Inflammation. Syed SN; Raue R; Weigert A; von Knethen A; Brüne B Cells; 2019 Jul; 8(8):. PubMed ID: 31357710 [TBL] [Abstract][Full Text] [Related]
9. The targetable nanoparticle BAF312@cRGD-CaP-NP represses tumor growth and angiogenesis by downregulating the S1PR1/P-STAT3/VEGFA axis in triple-negative breast cancer. Gong K; Jiao J; Xu C; Dong Y; Li D; He D; Zhao D; Yu J; Sun Y; Zhang W; Bai M; Duan Y J Nanobiotechnology; 2021 May; 19(1):165. PubMed ID: 34059068 [TBL] [Abstract][Full Text] [Related]
10. Differential expression of S1P receptor subtypes in human bladder transitional cell carcinoma. Palangi A; Shakhssalim N; Parvin M; Bayat S; Allameh A Clin Transl Oncol; 2019 Sep; 21(9):1240-1249. PubMed ID: 30712233 [TBL] [Abstract][Full Text] [Related]
11. Nanoparticle BAF312@CaP-NP Overcomes Sphingosine-1-Phosphate Receptor-1-Mediated Chemoresistance Through Inhibiting S1PR1/P-STAT3 Axis in Ovarian Carcinoma. Gong K; Dong Y; Wang L; Duan Y; Yu J; Sun Y; Bai M; Duan Y Int J Nanomedicine; 2020; 15():5561-5571. PubMed ID: 32801704 [TBL] [Abstract][Full Text] [Related]
12. S1PR1 signaling in cancer: A current perspective. Anu B; Namitha NN; Harikumar KB Adv Protein Chem Struct Biol; 2021; 125():259-274. PubMed ID: 33931142 [TBL] [Abstract][Full Text] [Related]
13. Sphingosine kinase/sphingosine 1-phosphate signaling in cancer therapeutics and drug resistance. Selvam SP; Ogretmen B Handb Exp Pharmacol; 2013; (216):3-27. PubMed ID: 23563649 [TBL] [Abstract][Full Text] [Related]
14. S1PR1 predicts patient survival and promotes chemotherapy drug resistance in gastric cancer cells through STAT3 constitutive activation. Song S; Min H; Niu M; Wang L; Wu Y; Zhang B; Chen X; Liang Q; Wen Y; Wang Y; Yi L; Wang H; Gao Q EBioMedicine; 2018 Nov; 37():168-176. PubMed ID: 30316864 [TBL] [Abstract][Full Text] [Related]
16. Targeting sphingosine-1-phosphate signaling for cancer therapy. Xie Z; Liu H; Geng M Sci China Life Sci; 2017 Jun; 60(6):585-600. PubMed ID: 28623546 [TBL] [Abstract][Full Text] [Related]
17. Sphingosine-1-phosphate promotes the proliferation and attenuates apoptosis of Endothelial progenitor cells via S1PR1/S1PR3/PI3K/Akt pathway. Wang H; Huang H; Ding SF Cell Biol Int; 2018 Nov; 42(11):1492-1502. PubMed ID: 29790626 [TBL] [Abstract][Full Text] [Related]
18. STAT3-induced S1PR1 expression is crucial for persistent STAT3 activation in tumors. Lee H; Deng J; Kujawski M; Yang C; Liu Y; Herrmann A; Kortylewski M; Horne D; Somlo G; Forman S; Jove R; Yu H Nat Med; 2010 Dec; 16(12):1421-8. PubMed ID: 21102457 [TBL] [Abstract][Full Text] [Related]
19. S1PR1-STAT3 signaling is crucial for myeloid cell colonization at future metastatic sites. Deng J; Liu Y; Lee H; Herrmann A; Zhang W; Zhang C; Shen S; Priceman SJ; Kujawski M; Pal SK; Raubitschek A; Hoon DSB; Forman S; Figlin RA; Liu J; Jove R; Yu H Cancer Cell; 2012 May; 21(5):642-654. PubMed ID: 22624714 [TBL] [Abstract][Full Text] [Related]
20. Emerging functional markers for cancer stem cell-based therapies: Understanding signaling networks for targeting metastasis. Marquardt S; Solanki M; Spitschak A; Vera J; Pützer BM Semin Cancer Biol; 2018 Dec; 53():90-109. PubMed ID: 29966677 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]